← Open Payments lookup

GINA HIGGINS: Open Payments

NPI 1114110160 · HOLYOKE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,908 in 121 payments from 16 companies in 2025. Trend: 2023 $248 · 2024 $1,904 · 2025 $2,908

Food & beverage: $2,908
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.26$630
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)25$510
Vanda Pharmaceuticals Inc.10$279
Teva Pharmaceuticals USA, Inc.7$219
Janssen Pharmaceuticals, Inc5$209
Otsuka America Pharmaceutical, Inc.9$185
Supernus Pharmaceuticals, Inc.11$183
Corium, LLC5$107
Takeda Pharmaceuticals U.S.A., Inc.3$102
Indivior Inc.3$101

Products named: COBENFY, CAPLYTA, FANAPT, UZEDY, Qelbree, ABILIFY ASIMTUFII, SPRAVATO, REXULTI.

Industry payments across MA — which companies pay providers there.